Design, docking, synthesis and anti-E. coli screening of novel thiadiazolo thiourea derivatives as possible inhibitors of Enoyl ACP reductase (FabI) enzyme

  • Sonia George Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu
  • Mohammed Basheer Ramzeena Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu
  • Sayee Vignesh Ram Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu
  • Senthil Kumar Selvaraj Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu
  • Shinu Rajan Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu
  • Thengungal Kochupappy Ravi Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu
Keywords: Docking, Enoyl ACP reductase, Thiadiazole, Thiourea

Abstract

A series of 1-phenyl-[5-substitutedphenyl)-1,3,4-thiadiazol-2-yl]-3-thiourea (3a-h) were synthesized and screened for their anti Escherichia coli potential. The characterization of the newly synthesized compounds was based upon their spectral data. The design of the title compounds was done utilizing the in silico methodology. Virtual screening technique was utilized for the identification of the lead, thiadiazole. The pharmacokinetic behavior was predicted by lead optimization and docking studies helped to analyze the binding interactions. Antibacterial activity of the title compounds were predicted by the PASS prediction software. The anti E. coli screening results showed that the derivatives, 3b and 3h possessed significant activity.

Downloads

Download data is not yet available.
Abstract
1377
Download
732 Read
147

References

Arslan H, Duran N, Borekci G, Koray Ozer C, Akbay C. Antimicrobial activity of some thiourea derivatives and their nickel and copper complexes. Molecules 2009; 14: 519-27.

Cappuccino JG, Sherman N. Microbiology: A laboratory manual. 3rd ed. New York, Benjamin Cummings Publishing Company, 1992, pp 51-66.

Helmut B, Petra W, Angela ET, Birgit L et al. Protein EnvM Is the NADH-dependent enoyl-ACP Reductase (FabI) of Escherichia coli. J Biol Chem. 1994; 269: 5493-96.

Jatav V, Mishra P, Kashaw S, Stables JP. Synthesis and CNS depressant activity of some novel 3-[5-substituted1, 3, 4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur J Med Chem. 2008; 43: 135-41.

Kuo MR, Morbidoni HR, Alland D, Sneddon SF, et al. Targeting tuberculosis and malaria through inhibition of enoyl reductase: Compound activity and structural data. J Biol Chem. 2003; 278: 20851-59.

Poroikov VV, Filimonov DA. How to acquire new biological activities in old compounds by computer prediction? J Comput Aided Mol Des. 2002; 16: 819-24.

Richard JH, Charles OR. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli. J Biol Chem. 1995; 270: 26538-42.

Roujeinikova A, Levy CW, Rowsell S, Sedelnikova S, et al. Crystallographic analysis of Triclosan bound to enoyl reductase. J Mol Biol. 1999; 294: 527-35.

Sonia G, Ravi TK. Design, synthesis and antitubercular screening of certain novel thiadiazolyl pyrrolidine carboxamides as enoyl acp reductase inhibitors. Int J Pharm Pharm Sci. 2011; 3: 280-84.

Sonia G, Ravi TK. Oxadiazolo pyrrolidine carboxamides as enoyl-ACP reductase inhibitors: Design, synthesis and antitubercular activity screening. Med Chem Res. 2012; 22: 3428-33.

Published
2014-01-31
How to Cite
George, S., M. Ramzeena, S. Ram, S. Selvaraj, S. Rajan, and T. Ravi. “Design, Docking, Synthesis and Anti-E. Coli Screening of Novel Thiadiazolo Thiourea Derivatives As Possible Inhibitors of Enoyl ACP Reductase (FabI) Enzyme”. Bangladesh Journal of Pharmacology, Vol. 9, no. 1, Jan. 2014, pp. 49-53, doi:10.3329/bjp.v9i1.16992.
Section
Research Articles